• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

December 14-15, 2010: Blood Products Advisory Committee Meeting Reference Document Topics I and II

References

Topic I: Risk of Dengue Virus Infection in Blood Donors

  • Chuang V, Wong T, Leung Y, Ma E, Law YL, Tsang O, et al. Review of dengue fever cases in Hong Kong during 1998 to 2005. Hong Kong Med J. 2008; 14: 170-177.
  • Lima M, Nogueira R, Schatzmayr H, Santos F. Comparison of Three Commercially Available Dengue NS1 Capture Assays for Active Diagnosis of Dengue in Brazil. PLoS Neglected Tropical Diseases. 2010; 4: e738.
  • Dutra N, de Paula M, Oliveira M, Oliveira L, de Paula S. The laboratorial diagnosis of dengue: Applications and implications. Journal of Global Infectious Diseases. 2009; 1: 38-44.
  • Kleinman S. West Nile virus and transfusion safety in North America: response to an emerging pathogen. ISBT Science Series. 2006; 1: 251-256.
  • Linnen J, Vinelli E, Sabino E, Tobler L, Hyland C, Lee TH et al. Dengue viremia in blood donors from Honduras, Brazil and Australia. Transfusion. 2008; 48: 1355-1362.
  • Mohammed H, Linnen J, Munoz-Jordan J, Tomashek K, Foster G, Broulik A et al. Dengue virus in blood donations, Puerto Rico, 2005. Transfusion. 2008; 48: 1348-1354.
  • Locally Acquired Dengue- Key West, Florida, 2009-2010. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. May 21, 2010. Vol. 59. No. 19. Pages 577-591.
  • Munoz-Jordan J, Collins C, Vergne E, Santiago G, Peterson L, Wellington S and Linnen J. Highly Sensitive Detection of Dengue Virus Nucleic Acid in Samples from Chronically Ill Patients. Journal of Clinical Microbiology. 2009; 47: 927-931.
  • Pok KY, Lai YL, Sng J, Ng LC. Evaluation of Nonstructural 1 Antigen Assays for the Diagnosis and Surveillance of Dengue in Singapore. Vector-Borne and Zoonotic Diseases. 2010; 10: 1-8.
  • Seed C, Kiely P, Hyland C, Keller A. The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia. Transfusion. 2009; 49: 1482-1487.
  • Sekaran S, Lan E, Mahesawarappa K, Appanna R, Subramaniam G. Evaluation of a Dengue NS1 capture ELISA assay for the rapid detection of Dengue. J Infect Developing Countries. 2007; 1: 182-188.
  • Stramer S, Linnen M, Carrick M et al. Dengue Donor Viremia Determined by RNA and NS1 Antigen, and Detection of Dengue Transfusion Transmission During the 2007 Dengue Outbreak in Puerto Rico. Vox Sang Science Series. 2010; 99 (S1): 3E-S18-02.
  • Tambyah P, Koay E, Poon M, Lin R, Ong B for the Transfusion-Transmitted Dengue Infection Study Group. Dengue Hemorrhagic Fever Transmitted by Blood Transfusion. 2008; 359: 1526-1527.
  • Tomashek K, Rivera A, Munoz-Jordan J, Hunsperger E, Santiago L, Padro O et al. Description of a Large Island-Wide Outbreak of Dengue in Puerto Rico, 2007. Am. J. Trop. Med. Hyg. 2009; 81: 467-474.
  • Tricou V, Vu H, Quynh N, Nguyen C, Tran H, Farrar J et al. Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infectious Diseases. 2010; 10: 142.
  • Wang S and Sekaran S. Evaluation of a commercial SD Dengue NS1 antigen capture ELISA kit for the early diagnosis of Dengue virus infection. J. Clin. Microbiology. 2010. doi:10.1128/JCM.02142-09. Published online ahead of print.
  • Wilder-Smith A, Chen L, Massad E and Wilson ME. Threat of Dengue to blood safety in dengue-Endemic countries. Emerging Infectious Diseases. 2009; 15: 8-11.

Topic II: Murine Leukemia Virus (MLV) - related Human Retroviruses and Blood Safety

  • Arnold R, Makarova N, Osunkoya A, Suppiah S, Scott T et al. XMRV Infection in Patients with Prostate Cancer: Novel Serologic Assay and Correlation with PCR and FISH. Cancer. Urology. 2010; 75: 755-761.
  • Baliji S, Liu Q and Kozak C. Common inbred strains of the laboratory mouse that are susceptible to infection by mouse xenotropic gammetroviruses and the human derived XMRV. JVI. 2010. Doi:10.1128/JVI.01863-10. Published online ahead of print.
  • Cornelissen M, Zorgdrager F, Blom P, Jurriaans S, Repping S et al. Lack of Detection of XMRV in Seminal Plasma from HIV-1 Infected Men in The Netherlands. PLoS One. 2010; 5: e12040.
  • Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, et al.: An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A 2007, 104:1655-1660.
  • Erlwein O et al. Failure to Detect the Novel Retrovirus XMRV in Chronic Fatigue Syndrome. PLoS ONE. 2010; 5: e8519. www.plosone.org
  • Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, Schlomm T. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 2008, 43:277-283.
  • Fischer N, Schulz C, Stieler K, Hohn O, Lange C, Drosten C, Aepfelbacher M. Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract. Emerg Infect Dis, 2010; 16:1000-1002.
  • Furuta RA, Miyazawa T, Sugiyama T, Kimura T, Hirayama F, Tani Y and Shibata H. The prevalence of xenotropic murine leukemia virus-related virus in healthy blood donors in Japan. In Retroviruses. pp. 100. Cold Spring Harbour Laboratory; 2009:100.
  • Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S, Hagan S, et al: Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology, 2010; 7:10.
  • Henrich TJ, Li JZ, Felsenstein D, Kotton CN, Plenge RM, Pereyra F, et al: Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. Journal of Infectious Diseases 2010, 202: in press.
  • Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, et al: Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 2009, 6:92.
  • Hong P, Li J, Li Y: Failure to detect xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J, 2010; 7:224.
  • Jeziorski E, Foulongne V, Ludwig C, Louhaem D, Chiocchia G, Segondy M et al. No Evidence for XMRV association in pediatric idiopathic diseases in France. Retrovirology. 2010; 7: 63.
  • Kunstman K, Bhattacharya T, Flaherty J, Phair J and Wolinksy S. Absence of xenotropic murine leukemia virus-related virus in blood cells of men at risk for and infected with HIV. AIDS. 2010; 24: 1784-1785.
  • Lo SC, Pripuzova N, Li B, Komaroff A, Hung GC, Wang R and Alter HJ: Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci. 2010; 107:15874-15879.
  • Lombardi VC et al. Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome. Science. 2009; 326: 585-589.
  • Lombardi VC, Ruscetti FW, Das Gupta J, Pfost M, Hagen K, Peterson D, et al: Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Virulence . 2010; 1: 5.
  • McClure M, Wessely S: Chronic fatigue syndrome and human retrovirus XMRV. BMJ, 2010; 340: 489-490.
  • Mikovits JA, Huang Y, Pfost M, Lombardi V, Bertolette D, Hagen K and Ruscetti F. Distribution of xenotropic murine leukemia-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer. AIDS Rev. 2010; 12: 149-152.
  • Qiu X, Swanson P, Luk KC, Tu B, Villinger F, Das Gupta J, et al. Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology. 2010; 7:68.
  • Satterfield B, Garcia R, Gurrieri F, Schwartz C. PCR and serology find no association between xenotropic murine leukemia virus-releated virus and autism. Molecular Autism. 2010; 1: 14.
  • Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci. 2009, 106:16351-16356.
  • Silverman RH et al. The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. Nature Reviews Urology. Published online ahead of print. June 1, 2010.
  • Singh IR. Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome. 2010; 5: e9948.
  • Switzer WM, Jia H, Hohn O, Zheng H, Tang S, Shankar A, et al: Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology. 2010; 7:57.
  • Switzer W et al. Prevalence of Xenotropic Murine Leukemia Virus in Prostate Cancer. Paper #149. 17 th Conference on Retroviruses and Opportunistic Infections. http://www.retroconference.org/2010/Abstracts/37160.htm.
  • Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, et al: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006, 2:e25.
  • van Kuppeveld F, de Jong A, Lanke K, Verhaegh G, Melchers W, Swanink C, et al.: Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ. 2010; 340:c1018.
  • Verhaegh G, de Jong A, Smit FP, Jannink SA, Melchers WJ, Schalken JA. Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in dutch prostate cancer patients. Prostate 2010: in press.
  • Weiss R. A cautionary tale of virus and disease. BMC Biology. 2010; 8: 124.
  • Yang, H., Lee, J., Seed, C.R. Keller, A. Can Blood Transfusion Transmit Cancer? A Literature Review. Transfusion Medicine Reviews. 2010, 24: 235-243.